Guilin Zhang

Union Hospital
Wuhan, 430022, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Development of multiphasic CT-based delta-radiomics model for predicting postoperative recurrence risk in bladder cancer.

Development of multiphasic CT-based delta-radiomics model for predicting postoperative recurrence risk in bladder cancer.

Journal: BMC medical imaging

Published: March 27, 2026

Tumor apparent diffusion coefficient as a predictive marker for PD-1 inhibitor outcome in advanced cervical cancer: a retrospective study.

Tumor apparent diffusion coefficient as a predictive marker for PD-1 inhibitor outcome in advanced cervical cancer: a retrospective study.

Journal: Frontiers in oncology

Published: January 12, 2026

Hypoxia-related and immune phenotype-related fusion model for non-invasive prognostication of hepatocellular carcinoma treated by TACE: a multicentre study.

Hypoxia-related and immune phenotype-related fusion model for non-invasive prognostication of hepatocellular carcinoma treated by TACE: a multicentre study.

Journal: Gut

Published: December 22, 2025

Association between splenic volume changes and prognosis in advanced gastric cancer patients receiving chemotherapy combined with immunotherapy.

Association between splenic volume changes and prognosis in advanced gastric cancer patients receiving chemotherapy combined with immunotherapy.

Journal: Frontiers in oncology

Published: December 09, 2025

A radiomics-based nomogram for preoperatively predicting the invasiveness of nodular lung adenocarcinoma: a multicenter study.

A radiomics-based nomogram for preoperatively predicting the invasiveness of nodular lung adenocarcinoma: a multicenter study.

Journal: Translational lung cancer research

Published: October 31, 2025

Hepatic immune prognostic index as a prognostic biomarker in hepatocellular carcinoma patients treated with transarterial chemoembolization.

Hepatic immune prognostic index as a prognostic biomarker in hepatocellular carcinoma patients treated with transarterial chemoembolization.

Journal: Therapeutic advances in medical oncology

Published: October 28, 2025

A DeepSeek-powered AI system for automated chest radiograph interpretation in clinical practice.

A DeepSeek-powered AI system for automated chest radiograph interpretation in clinical practice.

Journal: Nature communications

Published: August 31, 2025

Anti-CD24 Antibody Plus Liposomal Doxorubicin for the Management of Residual Cancers After Incomplete Radiofrequency Ablation.

Anti-CD24 Antibody Plus Liposomal Doxorubicin for the Management of Residual Cancers After Incomplete Radiofrequency Ablation.

Journal: ImmunoTargets and therapy

Published: May 29, 2025

Atezolizumab Plus Bevacizumab Combined with or without Transarterial Chemoembolization in the Treatment of Advanced Hepatocellular Carcinoma: A Single-Center Retrospective Study.

Atezolizumab Plus Bevacizumab Combined with or without Transarterial Chemoembolization in the Treatment of Advanced Hepatocellular Carcinoma: A Single-Center Retrospective Study.

Journal: Journal of hepatocellular carcinoma

Published: January 23, 2025

Clinical outcomes of carotid artery stenting with open- versus closed-cell stents.

Clinical outcomes of carotid artery stenting with open- versus closed-cell stents.

Journal: Journal of neurointerventional surgery

Published: January 06, 2025

Oncolytic peptide LTX-315 plus an anti-CTLA-4 antibody induces a synergistic anti-cancer immune response in residual tumors after radiofrequency ablation of hepatocellular carcinoma.

Oncolytic peptide LTX-315 plus an anti-CTLA-4 antibody induces a synergistic anti-cancer immune response in residual tumors after radiofrequency ablation of hepatocellular carcinoma.

Journal: Cell death & disease

Published: October 25, 2024

Transarterial Chemoembolization Plus Radiofrequency Ablation and Iodine-125 Seed Implantation for Hepatocellular Carcinoma in High-Risk Locations: A Propensity Score-Matched Analysis.

Transarterial Chemoembolization Plus Radiofrequency Ablation and Iodine-125 Seed Implantation for Hepatocellular Carcinoma in High-Risk Locations: A Propensity Score-Matched Analysis.

Journal: Journal of hepatocellular carcinoma

Published: October 25, 2024

Showing 1-12 of 16

Last Updated: 09/26/2026